Cardiovascular disease in Europe: epidemiological update.

This overview provides a Europe-wide update on the current burden of cardiovascular disease, and specifically of coronary heart disease and stroke. Cardiovascular disease continues to cause a large proportion of deaths and disability in Europe, and places a substantial burden on the health care systems and economies of Europe. The overall picture, and the distribution of the burden, continues to evolve in a developing Europe. There have been major improvements in recent years on many measures of cardiovascular disease; however, these improvements have not been universal, and substantial inequalities persist.

[1]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[2]  R. Brugada,et al.  Trends in Q-wave acute myocardial infarction case fatality from 1978 to 2007 and analysis of the effectiveness of different treatments. , 2011, American heart journal.

[3]  V. Feigin,et al.  Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review , 2009, The Lancet Neurology.

[4]  S. Allender,et al.  Cardiovascular disease in Europe , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[5]  F. Alla,et al.  Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010. , 2013, Archives of Cardiovascular Diseases.

[6]  Copenhagen,et al.  European Health for All Database (HFA-DB) , 2005 .

[7]  E. Dubljanin,et al.  Trends in mortality rates from coronary heart disease in Belgrade (Serbia) during the period 1990–2010: a joinpoint regression analysis , 2013, BMC Cardiovascular Disorders.

[8]  Roberto Ferrari,et al.  Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). , 2012, Circulation.

[9]  M. Goldacre,et al.  Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study , 2012, BMJ : British Medical Journal.

[10]  Ramon Luengo-Fernandez,et al.  European Cardiovascular Disease Statistics 2017 , 2012 .

[11]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[12]  S. Allender,et al.  European cardiovascular disease statistics , 2008 .

[13]  M. Chester.  Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults , 2008, Heart.

[14]  E. Ford,et al.  Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults , 2007, Heart.

[15]  K. Kotseva,et al.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[16]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[17]  Peter Scarborough,et al.  Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009 , 2013, European heart journal.

[18]  K. Kotseva,et al.  Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.

[19]  European guidelines on cardiovascular disease prevention in clinical practice (Version 2012) , 2012 .